Earnings History Data for ChemoCentryx, Inc. (CCXI) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

ChemoCentryx, Inc.

ChemoCentryx, Inc. is a biopharmaceutical company focused on discovering, developing and commercializing orally-administered therapeutics to treat autoimmune diseases, inflammatory disorders and cancer. ChemoCentryx, Inc. is headquartered in Mountain View, California.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
08-08-2022	AH	4:05 PM ET (Aug 9)	CCXI	ChemoCentryx, Inc.	1,580	-0.44	-0.51	-0.56	ChemoCentryx GAAP EPS of -$0.44 misses by $0.03, revenue of $11.76M misses by $9.89M [8/9/2022 4:42 PM]	50.88	0.09 (0.19%)	50.65	-0.14 (-0.28%)	13.11 - 50.94	3,405,255	6,290,000	2,845
ChemoCentryx GAAP EPS of -$0.44 misses by $0.03, revenue of $11.76M misses by $9.89M [8/9/2022 4:42 PM] ChemoCentryx Cancels Second Quarter 2022 Financial Results Conference Call [Aug-09-22 08:30AM]
05-05-2022	AH	4:05 PM ET (May 5)	CCXI	ChemoCentryx, Inc.	1,340	-0.55	-0.24	-0.43	ChemoCentryx GAAP EPS of -$0.55 misses by $0.24, revenue of $5.46M misses by $21.87M [5/5/2022 4:25 PM]	17.29	1.65 (10.55%)	17.32	1.68 (10.74%)	9.53 - 42.16	7,667,296	1,350,000	158,856
ChemoCentryx GAAP EPS of -$0.55 misses by $0.24, revenue of $5.46M misses by $21.87M [5/5/2022 4:25 PM] ChemoCentryx surges 15% despite top and bottom lines quarterly misses [5/6/2022 11:50 AM] ChemoCentryx Reports First Quarter 2022 Financial Results and Recent Highlights [May-05-22 04:05PM] ChemoCentryx (CCXI) Reports Q1 Loss, Misses Revenue Estimates [May-05-22 06:35PM] ChemoCentryx (CCXI) Q1 Earnings and Sales Miss Estimates [May-06-22 03:38PM]
01-03-2022	AH	4:05 PM ET (Mar 1)	CCXI	ChemoCentryx, Inc.	2,150	-0.58	-0.56	-0.43	ChemoCentryx GAAP EPS of -$0.58 in-line, revenue of $2.32M misses by $1.58M [3/1/2022 4:19 PM]	24.41	-5.05 (-17.14%)	25.01	-4.45 (-15.11%)	9.53 - 70.21	5,935,739	980,000	121,954
ChemoCentryx GAAP EPS of -$0.58 in-line, revenue of $2.32M misses by $1.58M [3/1/2022 4:19 PM] ChemoCentryx Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Highlights [Mar-01-22 04:05PM] ChemoCentryx (CCXI) Reports Q4 Loss, Lags Revenue Estimates [Mar-01-22 05:35PM] ChemoCentryx (CCXI) Q4 Earnings and Sales Miss Estimates [Mar-02-22 10:33AM] See Why Is Stifel Analyst 'Perplexed' After ChemoCentryx Q4 Earnings [Mar-02-22 01:51PM]
09-11-2021	AH	4:05 PM ET (Nov 9)	CCXI	ChemoCentryx, Inc.	2,710	-0.32	-0.45	-0.35	ChemoCentryx EPS beats by $0.13, beats on revenue [11/9/2021 4:08 PM]	38.05	0.03 (0.08%)	39.00	0.98 (2.58%)	9.53 - 70.29	2,430,816	1,400,000	15,865
ChemoCentryx EPS beats by $0.13, beats on revenue [11/9/2021 4:08 PM] Should You Buy ChemoCentryx (CCXI) Ahead of Earnings? [Nov-08-21 09:29AM] ChemoCentryx Reports Third Quarter 2021 Financial Results and Recent Highlights [Nov-09-21 04:05PM] ChemoCentryx (CCXI) Reports Q3 Loss, Tops Revenue Estimates [Nov-09-21 05:55PM] ChemoCentryx, inc (CCXI) Q3 2021 Earnings Call Transcript [Nov-10-21 01:01AM] Big Pharma Is Going Holiday Shopping. Who's Next? [Nov-10-21 06:20AM] ChemoCentryx to Participate in Two Upcoming Investor Conferences [Nov-10-21 08:00AM] ChemoCentryx (CCXI) Q3 Loss Narrower Than Expected, Sales Top [Nov-10-21 10:44AM]
09-08-2021	AH	4:05 PM ET (Aug 9)	CCXI	ChemoCentryx, Inc.	1,090	-0.56	-0.55	0.29	ChemoCentryx EPS misses by $0.02, misses on revenue [8/9/2021 4:13 PM]	14.33	-0.27 (-1.85%)	14.54	-0.06 (-0.41%)	9.53 - 70.29	1,610,073	1,290,000	17,712
ChemoCentryx EPS misses by $0.02, misses on revenue [8/9/2021 4:13 PM] Lifshitz Law Firm, P.C. Announces Investigations of 3D Systems Corp. (NYSE: DDD), Acadia Pharmaceuticals, Inc. (NasdaqGS: ACAD), ChemoCentryx, Inc. (NasdaqGS: CCXI), and Peloton Interactive, Inc (NasdaqGS: PTON) [Aug-06-21 01:54PM] ChemoCentryx Reports Second Quarter 2021 Financial Results and Recent Highlights [Aug-09-21 04:05PM] ChemoCentryx (CCXI) Reports Q2 Loss, Lags Revenue Estimates [Aug-09-21 05:55PM] ChemoCentryx, inc (CCXI) Q2 2021 Earnings Call Transcript [Aug-10-21 08:01AM] ChemoCentryx (CCXI) Q2 Loss Wider Than Expected, Sales Down [Aug-10-21 10:54AM]
29-04-2021	AH	4:05 PM ET (Apr 29)	CCXI	ChemoCentryx, Inc.	3,300	-0.43	-0.40	-0.35	ChemoCentryx EPS misses by $0.03, beats on revenue [4/29/2021 4:26 PM]	48.45	3.45 (7.67%)	45.50	0.50 (1.11%)	44.28 - 70.29	828,822	480,000	489
ChemoCentryx EPS misses by $0.03, beats on revenue [4/29/2021 4:26 PM] ChemoCentryx Reports First Quarter 2021 Financial Results and Recent Highlights [Apr-29-21 04:05PM] ChemoCentryx (CCXI) Reports Q1 Loss, Tops Revenue Estimates [Apr-29-21 05:45PM] ChemoCentryx Inc (CCXI) Q1 2021 Earnings Call Transcript [Apr-30-21 06:01PM]
01-03-2021	AH	4:05 PM ET (Mar 1)	CCXI	ChemoCentryx, Inc.	4,560	-0.43	-0.32	-0.26	ChemoCentryx EPS misses by $0.10, misses on revenue [3/1/2021 4:16 PM]	66.79	-1.61 (-2.35%)	68.00	-0.40 (-0.58%)	30.72 - 70.29	486,438	464,735	2,080
ChemoCentryx EPS misses by $0.10, misses on revenue [3/1/2021 4:16 PM] ChemoCentryx (CCXI) Q4 Loss Wider Than Expected, Sales Miss [Mar-02-21 12:54PM] ChemoCentryx (CCXI) Reports Q4 Loss, Misses Revenue Estimates [Mar-01-21 06:25PM]
09-11-2020	AH	4:05 PM ET (Nov 9)	CCXI	ChemoCentryx, Inc.	3,760	-0.35	-0.28	-0.22	ChemoCentryx, Inc. EPS misses by $0.04, misses on revenue [11/9/2020 4:07 PM]	57.94	-0.04 (-0.07%)	53.91	-4.07 (-7.01%)	7.88 - 65.43	495,396	786,470	1,253

10-08-2020	AH	4:05 PM ET (Aug 10)	CCXI	ChemoCentryx, Inc.	3,700	0.29	-0.34	-0.26	ChemoCentryx, Inc. EPS beats by $0.63, beats on revenue [8/10/2020 4:24 PM]	57.18	1.46 (2.61%)	55.70	-0.02 (-0.04%)	6.37 - 65.43	363,871	583,589	3,397